Pierre Jacquet's most recent trade in Mereo Biopharma Group Plc - ADR was a trade of 55,000 Share Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Mereo Biopharma Group Plc ... | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
Mereo Biopharma Group Plc ... | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 15,243 | 15,243 | - | - | Deferred Restricted Stock Units | |
Mereo Biopharma Group Plc ... | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
Mereo Biopharma Group Plc ... | Jacquet Pierre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 15,553 | 15,553 | - | - | Deferred Restricted Stock Units | |
Exact Sciences Corp. | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 4,580 | 23,576 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 7,243 | 18,996 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 2,599 | 11,753 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2020 | 420 | 9,154 (0%) | 0% | 0 | Common Stock | |
Exact Sciences Corp. | Pierre Jacquet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2020 | 2,752 | 8,734 (0%) | 0% | 0 | Common Stock |